Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells.
Functional drug carriers formed by RGD-modified β-CD-HPG for the delivery of docetaxel for targeted inhibition of nasopharyngeal carcinoma cells.
复制标题
作者:
In this study, a drug delivery system was prepared by grafting the targeting molecule arginine-glycine-aspartic acid (RGD) onto hyperbranched polyglycerol (HPG)-modified β-cyclodextrin (β-CD-HPG) for the targeted inhibition of nasopharyngeal carcinoma (NPC) cells. The obtained β-CD-HPG-RGD with a relatively small size and low surface charge delivered docetaxel (Doc) effectively and displayed a targeting effect to human NPC HNE-1 cells, as confirmed by confocal laser scanning microscopy and flow cytometry. The in vitro drug release analysis exhibited the controlled drug release kinetics of the β-CD-HPG-RGD/Doc nanomedicine. β-CD-HPG-RGD/Doc effectively inhibited the proliferation of HNE-1 cells and promoted apoptosis. Moreover, its biocompatibility in vitro and in vivo was assessed. The results indicate that the β-CD-HPG-RGD/Doc nanomedicine has potential application in NPC targeting therapy. A new RGD targeting drug carrier based on HPG-modified β-CD has been synthesized. This carrier showed excellent biocompatibility and targeting ability. The obtained NPs could effectively inhibit the proliferation of tumor cells.
登录
查看更多内容
DOI:
10.1016/j.ijbiomac.2009.11.008
发表时间:
2010-03-01
影响因子:
8.2
作者:
Cao, Yu;Gu, Ying;He, Hongxuan
通讯作者:
He, Hongxuan
影响因子:
5.8
作者:
Hami, Zahra;Amini, Mohsen;Gilani, Kambiz
通讯作者:
Gilani, Kambiz
影响因子:
10.8
作者:
Kim, SY;Ha, JC;Lee, YM
通讯作者:
Lee, YM
影响因子:
3.7
作者:
Gao, Jinzhi;Zhang, Cai;Luo, Xiaoping
通讯作者:
Luo, Xiaoping
影响因子:
6
作者:
Liu, Tao;Wu, Xidong;Zhang, Siyi
通讯作者:
Zhang, Siyi